We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
+7.26%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.46B
AUM Growth
-$34.2M
(-1.4%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-4.63%
Top 10 Holdings %
Top 10 Hldgs %
7.2%
Holding
2,015
New
556
Increased
372
Reduced
436
Closed
645
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$17.3M |
| 2 |
Walt Disney
DIS
|
+$17.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$16M |
| 4 |
Nektar Therapeutics
NKTR
|
+$15M |
| 5 |
Halliburton
HAL
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$24.9M |
| 2 |
Boeing
BA
|
+$23.2M |
| 3 |
Electronic Arts
EA
|
+$20M |
| 4 |
Five Below
FIVE
|
+$19.6M |
| 5 |
Avis
CAR
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.32% |
| 2 | Industrials | 13.59% |
| 3 | Technology | 11.91% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
NatWest
NWG
$70.6B
| $177K | 0.01% |
24,236
-65,743
| -73% | -$529K |
|
|
CDMO
1252
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $176K | 0.01% |
45,056
+16,101
| +56% | +$55.9K |
|
1253
Cameco
CCJ
$37.9B
| $174K | 0.01% |
+15,501
| New | +$169K |
|
1254
Ardmore Shipping
ASC
$669M
| $173K | 0.01% |
21,104
+5,700
| +37% | +$45.7K |
|
1255
Kosmos Energy
KOS
$1.39B
| $172K | 0.01% |
20,902
-125,821
| -86% | -$919K |
|
|
CMBT
1256
CMB.TECH NV
CMBT
$4.47B
| $171K | 0.01% |
+18,620
| New | +$163K |
|
1257
IAMGOLD
IAG
$8.24B
| $168K | 0.01% |
+29,021
| New | +$167K |
|
|
ZYNE
1258
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $165K | 0.01% |
16,961
-69,916
| -80% | -$717K |
|
|
CS
1259
DELISTED
Credit Suisse Group
CS
| $165K | 0.01% |
11,107
-116,500
| -91% | -$1.88M |
|
1260
Vitamin Cottage Natural Grocers
NGVC
$744M
| $164K | 0.01% |
12,877
-10,801
| -46% | -$104K |
|
1261
Newmark Group
NMRK
$2.88B
| $164K | 0.01% |
+11,550
| New | +$169K |
|
1262
Viking Therapeutics
VKTX
$3.93B
| $163K | 0.01% |
+17,208
| New | +$114K |
|
1263
Option Care Health
OPCH
$3.53B
| $162K | 0.01% |
13,839
+7,475
| +117% | +$78.3K |
|
1264
Flotek Industries
FTK
$856M
| $157K | 0.01% |
8,144
-8,934
| -52% | -$221K |
|
1265
LSB Industries
LXU
$822M
| $155K | 0.01% |
+38,155
| New | +$163K |
|
1266
ICL Group
ICL
$6.76B
| $153K | 0.01% |
33,428
-25,710
| -43% | -$118K |
|
|
ACET
1267
DELISTED
Aceto Corp
ACET
| $153K | 0.01% |
+45,845
| New | +$180K |
|
|
NEOS
1268
DELISTED
Neos Therapeutics, Inc
NEOS
| $152K | 0.01% |
+24,381
| New | +$182K |
|
|
IMDZ
1269
DELISTED
Immune Design Corp.
IMDZ
| $150K | 0.01% |
+33,067
| New | +$132K |
|
|
ESND
1270
DELISTED
Essendant Inc.
ESND
| $145K | 0.01% |
10,974
-55,272
| -83% | -$625K |
|
1271
Nomura Holdings
NMR
$28.1B
| $143K | 0.01% |
30,000
-4,000
| -12% | -$21.8K |
|
|
XONE
1272
DELISTED
The ExOne Company
XONE
| $141K | 0.01% |
19,969
-10,200
| -34% | -$71.7K |
|
1273
Talphera
TLPH
$67.5M
| $138K | 0.01% |
2,050
-1,650
| -45% | -$98.1K |
|
|
TRVN
1274
DELISTED
Trevena, Inc.
TRVN
| $136K | 0.01% |
+151
| New | +$166K |
|
1275
Cytosorbents Corp
CTSO
$23.3M
| $132K | 0.01% |
+11,647
| New | +$110K |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, A.R.T. Advisors held 2,015 positions worth $2.46B, down 1.4% from $2.49B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
A.R.T. Advisors withdrew a net $114M in Q2 2018, closing 645 positions and reducing 436 holdings. Its most notable exit was Five Below, an estimated $19.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.
Against the trend, A.R.T. Advisors opened a new position in Celgene Corp worth $16.6M.
- A.R.T. Advisors's largest Q2 2018 buy was Celgene Corp: 208,600 shares worth $16.6M.
- A.R.T. Advisors added most to Walt Disney in Q2 2018, an estimated $17.3M increase.
- A.R.T. Advisors's biggest Q2 2018 reduction was Ulta Beauty, cutting an estimated $24.9M.
- A.R.T. Advisors fully exited Five Below in Q2 2018, selling an estimated $19.6M.
- A.R.T. Advisors's ten largest holdings make up 7.2% of its $2.46B portfolio in Q2 2018.
- A.R.T. Advisors opened 556 new positions and closed 645 in Q2 2018.
- A.R.T. Advisors's portfolio value fell 1.4% quarter-over-quarter to $2.46B.
Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.